These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 35657072)

  • 1. Microfluidic T Cell Selection by Cellular Avidity.
    Ashby JF; Schmidt J; Kc N; Kurum A; Koch C; Harari A; Tang L; Au SH
    Adv Healthc Mater; 2022 Aug; 11(16):e2200169. PubMed ID: 35657072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High Peptide Dose Vaccination Promotes the Early Selection of Tumor Antigen-Specific CD8 T-Cells of Enhanced Functional Competence.
    Carretero-Iglesia L; Couturaud B; Baumgaertner P; Schmidt J; Maby-El Hajjami H; Speiser DE; Hebeisen M; Rufer N
    Front Immunol; 2019; 10():3016. PubMed ID: 31969886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow cytometry-based TCR-ligand Koff -rate assay for fast avidity screening of even very small antigen-specific T cell populations ex vivo.
    Nauerth M; Stemberger C; Mohr F; Weißbrich B; Schiemann M; Germeroth L; Busch DH
    Cytometry A; 2016 Sep; 89(9):816-25. PubMed ID: 27564267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD4-independent T cells impair TCR triggering of CD4-dependent T cells: a putative mechanism for T cell affinity maturation.
    van Bergen J; Kooy Y; Koning F
    Eur J Immunol; 2001 Feb; 31(2):646-52. PubMed ID: 11180130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene transfer of tumor-reactive TCR confers both high avidity and tumor reactivity to nonreactive peripheral blood mononuclear cells and tumor-infiltrating lymphocytes.
    Johnson LA; Heemskerk B; Powell DJ; Cohen CJ; Morgan RA; Dudley ME; Robbins PF; Rosenberg SA
    J Immunol; 2006 Nov; 177(9):6548-59. PubMed ID: 17056587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Avidity characterization of genetically engineered T-cells with novel and established approaches.
    Hillerdal V; Boura VF; Björkelund H; Andersson K; Essand M
    BMC Immunol; 2016 Jul; 17(1):23. PubMed ID: 27411667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Avidity optimization of a MAGE-A1-specific TCR with somatic hypermutation.
    Bassan D; Gozlan YM; Sharbi-Yunger A; Tzehoval E; Greenstein E; Bitan L; Friedman N; Eisenbach L
    Eur J Immunol; 2021 Jun; 51(6):1505-1518. PubMed ID: 33835499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a T-cell receptor multimer with high avidity for detecting a naturally presented tumor-associated antigen on osteosarcoma cells.
    Watanabe K; Tsukahara T; Toji S; Saitoh S; Hirohashi Y; Nakatsugawa M; Kubo T; Kanaseki T; Kameshima H; Terui T; Sato N; Torigoe T
    Cancer Sci; 2019 Jan; 110(1):40-51. PubMed ID: 30375705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-Throughput Single-Cell TCR-pMHC Dissociation Rate Measurements Performed by an Autonomous Microfluidic Cellular Processing Unit.
    Jammes F; Schmidt J; Coukos G; Maerkl SJ
    ACS Sens; 2022 Jan; 7(1):159-165. PubMed ID: 35006683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural high-avidity T-cell receptor efficiently mediates regression of cancer/testis antigen 83 positive common solid cancers.
    Li Q; Hu W; Liao B; Song C; Li L
    J Immunother Cancer; 2022 Jul; 10(7):. PubMed ID: 35798537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased TCR avidity after T cell activation: a mechanism for sensing low-density antigen.
    Fahmy TM; Bieler JG; Edidin M; Schneck JP
    Immunity; 2001 Feb; 14(2):135-43. PubMed ID: 11239446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positive selection of low responsive, potentially autoreactive T cells induced by high avidity, non-deleting interactions.
    Chidgey AP; Boyd RL
    Int Immunol; 1998 Jul; 10(7):999-1008. PubMed ID: 9701038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Quest for the Best: How TCR Affinity, Avidity, and Functional Avidity Affect TCR-Engineered T-Cell Antitumor Responses.
    Campillo-Davo D; Flumens D; Lion E
    Cells; 2020 Jul; 9(7):. PubMed ID: 32708366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Essential Role of the Avidity of T-Cell Receptor in Differentiation of Self-Antigen-reactive CD8+ T Cells.
    Kondo K; Fujiki F; Nakajima H; Yatsukawa E; Morimoto S; Tatsumi N; Nishida S; Nakata J; Oka Y; Tsuboi A; Hosen N; Oji Y; Sugiyama H
    J Immunother; 2016 Apr; 39(3):127-39. PubMed ID: 26938946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimelanoma activity of CTL generated from peripheral blood mononuclear cells after stimulation with autologous dendritic cells pulsed with melanoma gp100 peptide G209-2M is correlated to TCR avidity.
    Yang S; Linette GP; Longerich S; Haluska FG
    J Immunol; 2002 Jul; 169(1):531-9. PubMed ID: 12077285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Rare High-Avidity, Tumor-Reactive CD8+ T Cells by Monomeric TCR-Ligand Off-Rates Measurements on Living Cells.
    Hebeisen M; Schmidt J; Guillaume P; Baumgaertner P; Speiser DE; Luescher I; Rufer N
    Cancer Res; 2015 May; 75(10):1983-91. PubMed ID: 25808864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A low antigen dose selectively promotes expansion of high-avidity autoreactive T cells with distinct phenotypic characteristics: a study of human autoreactive CD4+T cells specific for GAD65.
    Oling V; Geubtner K; Ilonen J; Reijonen H
    Autoimmunity; 2010 Dec; 43(8):573-82. PubMed ID: 20370569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two intermediate-avidity cytotoxic T lymphocyte clones with a disparity between functional avidity and MHC tetramer staining.
    Derby MA; Wang J; Margulies DH; Berzofsky JA
    Int Immunol; 2001 Jun; 13(6):817-24. PubMed ID: 11369710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation of high avidity melanoma-reactive CTL from heterogeneous populations using peptide-MHC tetramers.
    Yee C; Savage PA; Lee PP; Davis MM; Greenberg PD
    J Immunol; 1999 Feb; 162(4):2227-34. PubMed ID: 9973498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineering improved T cell receptors using an alanine-scan guided T cell display selection system.
    Malecek K; Zhong S; McGary K; Yu C; Huang K; Johnson LA; Rosenberg SA; Krogsgaard M
    J Immunol Methods; 2013 Jun; 392(1-2):1-11. PubMed ID: 23500145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.